An investigation by Kaiser Health News and the USA TODAY Network discovers that more than 260 patients have died since 2013 after in-and-out procedures at surgery centers across the country. More than a dozen — some as young as 2 — have perished after routine operations, such as colonoscopies and tonsillectomies.
The inspector general at Health and Human Services says defective pacemakers or defibrillators had to be replaced from 2005 through 2014, costing Medicare $1.5 billion.
Some teens and young adults are spending weeks or even months in retrofitted emergency rooms — even in mesh-covered tents — until specialized care can be found. ‘It’s a huge problem,’ one doctor says.
Prosecutors say hedge-fund traders made millions trading on information leaked from Medicare.
The HHS inspector general’s office found that Medicare should have done an in-depth review of suspicious or aberrant infection reports from scores of hospitals.
With federal investigators bearing down on his committee, Rep. Tom Price, who is in line to be secretary of HHS, showed little restraint in investing in health companies.
Despite questions about Lupron’s lasting side effects and minimal study into its safety, the FDA sped approval of the drug to market. Years later, some young women are still living with the consequences.
Concerns over U.S. Rep. Tom Price’s answers about stock trades led Senate Democrats to boycott a committee vote that would have moved his nomination to the Senate floor.
Rep. Tom Price, up for running HHS under President Trump, helped a company that became a top campaign donor, records show.
Letters sent to Medicare from U.S. Rep. Tom Price, President Trump’s pick to run HHS, supported physicians as well as drug or device makers, records show.